Valneva vaccine - a French game changer? ... Not so fast...
Manufactured in a traditional way, by growing the inactivated virus, Valneva's vaccine could convince mRNA sceptics to reconsider and benefit from surging - and unmet - demand in developing countries, provided the firm scales production successfully










